New Enterprise Associates 13 LP

New Enterprise Associates 13 LP is a declared insider at 22 companies; the most frequent names are TESARO, Inc., Epizyme, Inc. and Ra Pharmaceuticals, Inc. In total, 113 filings cover trades dated from 21 November 2011 to 14 March 2025.

Market trades split into 30 purchases (€139.6M) and 17 sales (€131.5M). Purchases outweigh sales by €8.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants. Since January 2025: no purchases and 8 sales on the market.

A typical purchase (the median) is worth €2.7M. Of 17 purchases, 16 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 14 March 2025 with an open-market sale (€114k) in BuzzFeed, Inc. The most recent open-market purchase was published on 20 July 2023, 1,191 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.